Cramer’s Homework: CLMT Doesn’t Add Up

[cnbc 3000046191]

Cramer sharpens his pencil on Calumet Specialty Products and says lackluster growth, plus unsteady cash flow, plus distribution problems, plus a spotty history, equals a stock investors should stay away.

With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.

Video © and provided by CNBC.

Be the first to comment

Leave a Reply